Skip to main content
. 2018 Feb 9;15(4):5947–5951. doi: 10.3892/ol.2018.8016

Figure 2.

Figure 2.

The Kaplan-Meier survival curves of the miRNA-195 Group I and II (61 patients) as well as Group III and IV (143 patients) among CCA patients. The 5-year survival rate in Group I and II is higher than that in Group III and IV among CCA patients (P=0.0026) (P<0.05).